Irbesartan use in specific populations: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Irbesartan}} {{CMG}}; {{AE}} {{SS}} =Use In Specific Populations== <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AVAPRO (IRBESARTA...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Irbesartan#Use in Specific Populations]]
{{Irbesartan}}
{{CMG}}; {{AE}} {{SS}}
 
=Use In Specific Populations==
 
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = AVAPRO (IRBESARTAN) TABLET [SANOFI-AVENTIS U.S. LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7885b2a8-be4e-48ab-8113-4e6ab791eb98 | publisher =  | date =  | accessdate = 20 February 2014 }}</ref>
 
==References==
 
{{Reflist}}
 
{{Angiotensin II receptor antagonists}}
 
[[Category:Angiotensin II receptor antagonists]]
[[Category:Sanofi]]
[[Category:Bristol-Myers Squibb]]
[[Category:Tetrazoles]]
[[Category:Biphenyls]]
[[Category:Lactams]]
[[Category:Spiro compounds]]
[[Category:Nitrogen heterocycles]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 01:11, 22 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Irbesartan_use_in_specific_populations&oldid=998114"